Patient Perspective: Me, Myself, and Scanxiety

In Brief for Feb. 22, 2023

Narrow Focus Allows Pragmatica-Lung Trial to Minimize Eligibility Criteria, Significantly Reduce Data Collection, Researcher Says

Tobacco Control Impacts Everyone in Respiratory Medicine, JTO CRR Editor Says

Patient Perspective: ‘Scanxiety’ Triggered by Cancer, Not Scans

TTLC Keynote Speaker Explores Progress, Potential Breakthroughs of SCLC Therapies

Experts Debate TKI Use After Disease Progression for Patients with EGFR Mutations

Scenes from TTLC 2023

Pragmatic Approach to Trial Design Born from Lung-MAP Substudy

ILCN Editor Dr. Corey J. Langer Reflects on the ‘Fantastic Voyage’ From Nihilism to Hope in Thoracic Oncology

Specialists Debate the Merits of Lorlatinib as a Universal First-Line Treatment for ALK+ Patients

Study Explores First-Line Osimertinib for NSCLC Patients with Uncommon EGFR Mutations